|
|
Article: Poland Pharamceuticals and Healthcare Report Q1 2009.
- Article from:
- M2 Presswire
- Article date:
- April 15, 2009
CopyrightCOPYRIGHT 2009 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-15 April 2009-www.companiesandmarkets.com: Poland Pharamceuticals and Healthcare Report Q1 2009(C)1994-2009 M2 COMMUNICATIONS LTD
RDATE:15042009
-www.companiesandmarkets.com adds new report: Poland Pharamceuticals and Healthcare Report Q1 2009
Poland's pharmaceutical market remains heavily pro-generic, meaning opportunities for innovative drugmakers are limited. Nevertheless, the sheer size of the overall pharmaceutical market - which makes it the third largest in Central and Eastern Europe (CEE) - means the country still represents significant opportunities for a diverse range of pharmaceutical companies. This is reinforced by ...